Robert Thomas Gabor

All filings by Robert Thomas Gabor on record concern Cytophage Technologies Ltd. Over a trading history stretching from 2 February 2024 to 31 July 2025, the count stands at 2 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 14 August 2025 came the latest disclosure, a share grant in Cytophage Technologies Ltd. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.